Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06174727 · ClinicalTrials.gov registry record

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

A clinical trial of Intracranial Aneurysm, sponsored by Montefiore Medical Center.

Recruiting
Registry status
5,000
Enrollment target
11
Study locations

NCT06174727 is a study of Intracranial Aneurysm that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 5,000 participants, below the 8,839-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (43% lower). The trial reports 11 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06174727, a study of Intracranial Aneurysm, is actively recruiting participants, sponsored by Montefiore Medical Center.

RECRUITING
Registry status
5,000 participants
Enrollment target
11
Study locations

Study Summary

This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.

Conditions Studied

Study Locations (11)

Florida

  • University of Miami - Coral Gables
  • Mayo Clinic Florida - Jacksonville
  • Sarasota Memorial Research Institute - Sarasota

New York

  • University at Buffalo - Buffalo
  • Montefiore Medical Center Department of Neurosurgery - The Bronx

Massachusetts

  • Lahey Hospital and Medical Center - Burlington

Michigan

  • Munson Medical Center - Traverse City

New Jersey

  • Robert Wood Johnson University - New Brunswick

Pennsylvania

  • Geisinger Health - Danville

Texas

  • HCA Houston Healthcare Kingwood - Kingwood

Ontario

  • Toronto Western Hospital - Toronto

Trial Details

FieldValue
Enrollment Target 5,000 participants
Start Date 2023-10-01
Est. Completion 2026-06

Sponsor

Montefiore Medical Center

345 total trials

What the Registry Record Tells You About NCT06174727

The ClinicalTrials.gov registry entry for NCT06174727 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 8,839-participant average among 14 other Intracranial Aneurysm trials with a reported enrollment target (43% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Intracranial Aneurysm appearing as the primary indexed condition, and to 0 interventions.

NCT06174727 reports 11 study locations spanning 8 distinct geographic areas - top geographies include Florida, New York, Massachusetts.

Frequently Asked Questions

What is clinical trial NCT06174727 about?

NCT06174727 is a clinical study titled "International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)". This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.

What is the current status of trial NCT06174727?

This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2023-10-01. Estimated completion is 2026-06.

What conditions does trial NCT06174727 study?

This clinical trial studies the following conditions: Intracranial Aneurysm.

Who is sponsoring clinical trial NCT06174727?

This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06174727 being conducted?

This trial has 11 study locations across Florida, Massachusetts, Michigan, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Intracranial Aneurysm

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.